Kfir Feffer

2.1k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Kfir Feffer is a scholar working on Cognitive Neuroscience, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Kfir Feffer has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cognitive Neuroscience, 8 papers in Neurology and 7 papers in Psychiatry and Mental health. Recurrent topics in Kfir Feffer's work include Transcranial Magnetic Stimulation Studies (8 papers), Functional Brain Connectivity Studies (6 papers) and Treatment of Major Depression (4 papers). Kfir Feffer is often cited by papers focused on Transcranial Magnetic Stimulation Studies (8 papers), Functional Brain Connectivity Studies (6 papers) and Treatment of Major Depression (4 papers). Kfir Feffer collaborates with scholars based in Israel, Canada and United States. Kfir Feffer's co-authors include Jonathan Downar, Zafiris J. Daskalakis, Daniel M. Blumberger, Sidney H. Kennedy, Fidel Vila‐Rodriguez, Peter Giacobbe, Raymond W. Lam, Kevin E. Thorpe, Yoshihiro Noda and Yuliya Knyahnytska and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

Kfir Feffer

19 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial

2018 748 citations Daniel M. Blumberger, Fidel Vila‐Rodriguez et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kfir Feffer Israel	9	899	625	304	201	150	19	1.2k
Yuliya Knyahnytska Canada	15	967 1.1×	635 1.0×	353 1.2×	192 1.0×	170 1.1×	39	1.4k
Susan McQueen Australia	15	789 0.9×	557 0.9×	356 1.2×	153 0.8×	151 1.0×	16	1.0k
Paul Zarkowski United States	9	866 1.0×	498 0.8×	322 1.1×	231 1.1×	152 1.0×	19	1.0k
Peter Bulow United States	6	746 0.8×	441 0.7×	305 1.0×	175 0.9×	134 0.9×	6	902
Peter Giacobbe Canada	15	857 1.0×	765 1.2×	198 0.7×	138 0.7×	197 1.3×	36	1.3k
Laís B. Razza Brazil	18	1.3k 1.5×	791 1.3×	529 1.7×	189 0.9×	233 1.6×	47	1.7k
Daniel M. Blumberger Canada	21	1.1k 1.3×	860 1.4×	479 1.6×	131 0.7×	203 1.4×	70	1.5k
Christopher A. Wall United States	13	619 0.7×	400 0.6×	379 1.2×	108 0.5×	174 1.2×	22	997
E. Baron Short United States	17	462 0.5×	315 0.5×	267 0.9×	126 0.6×	150 1.0×	42	1000
Monica Molloy United States	14	1.1k 1.2×	679 1.1×	410 1.3×	251 1.2×	162 1.1×	24	1.4k

Countries citing papers authored by Kfir Feffer

Since Specialization

Citations

This map shows the geographic impact of Kfir Feffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kfir Feffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kfir Feffer more than expected).

Fields of papers citing papers by Kfir Feffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kfir Feffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kfir Feffer. The network helps show where Kfir Feffer may publish in the future.

Co-authorship network of co-authors of Kfir Feffer

This figure shows the co-authorship network connecting the top 25 collaborators of Kfir Feffer. A scholar is included among the top collaborators of Kfir Feffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kfir Feffer. Kfir Feffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Shelef, Assaf, et al.. (2024). Efficacy of Esketamine among patients with treatment resistant depression in a ‘real world' health-care setting in Israel. Journal of Psychiatric Research. 174. 66–72. 1 indexed citations

Meiri, David, et al.. (2024). Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy. Psychiatry Research. 337. 115967–115967. 1 indexed citations

Feffer, Kfir, Wei Wu, Amit Etkin, et al.. (2021). Dorsomedial prefrontal rTMS for depression in borderline personality disorder: A pilot randomized crossover trial. Journal of Affective Disorders. 301. 273–280. 14 indexed citations

Brande-Eilat, Noa, Aviv Segev, Kfir Feffer, et al.. (2021). Methylphenidate reduces orienting bias in healthy individuals. Journal of Psychopharmacology. 35(6). 760–767. 4 indexed citations

Kaster, Tyler S., Jonathan Downar, Fidel Vila‐Rodriguez, et al.. (2019). Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. American Journal of Psychiatry. 176(5). 367–375. 100 indexed citations

Blumberger, Daniel M., Fidel Vila‐Rodriguez, Kevin E. Thorpe, et al.. (2018). Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. The Lancet. 391(10131). 1683–1692. 748 indexed citations breakdown →

Giacobbe, Peter, et al.. (2018). Improvements in Health-Related Quality of Life With Electroconvulsive Therapy. Journal of Ect. 34(2). 87–94. 17 indexed citations

Gvirts, Hila Z., et al.. (2018). The effect of methylphenidate on decision making in patients with borderline personality disorder and attention-deficit/hyperactivity disorder. International Clinical Psychopharmacology. 33(4). 233–237. 7 indexed citations

Feffer, Kfir, et al.. (2017). Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression. European Psychiatry. 44. 61–67. 8 indexed citations

10.

Feffer, Kfir, Farrokh Mansouri, Peter Giacobbe, et al.. (2017). Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression. Brain stimulation. 11(1). 181–189. 45 indexed citations

11.

Schulze, Laura, Kfir Feffer, Christopher S. Lozano, et al.. (2017). Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression. Brain stimulation. 11(2). 327–336. 87 indexed citations

12.

Feffer, Kfir, Peter Fettes, Peter Giacobbe, et al.. (2017). 1 Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomes. European Neuropsychopharmacology. 28(1). 109–117. 69 indexed citations

13.

Feffer, Kfir, et al.. (2017). Safety, feasibility, and efficacy of rTMS for major depression in borderline personality disorder: A 2-case report. Brain stimulation. 10(2). 474–474. 2 indexed citations

14.

Dunlop, Katharine, D. Blake Woodside, Patricia Colton, et al.. (2017). A randomized comparison of 1 Hz vs. 20 Hz vs. sham dorsomedial prefrontal rTMS for treatment-resistant depression: Preliminary clinical results. Brain stimulation. 10(2). 464–464. 4 indexed citations

15.

Feffer, Kfir, et al.. (2016). A comparative study with depressed patients on the acceptability of placebo use. General Hospital Psychiatry. 41. 53–56. 8 indexed citations

16.

Segev, Aviv, Hila Z. Gvirts, Naama Mayseless, et al.. (2016). A possible effect of methylphenidate on state anxiety: A single dose, placebo controlled, crossover study in a control group. Psychiatry Research. 241. 232–235. 10 indexed citations

17.

Gvirts, Hila Z., Naama Mayseless, Aviv Segev, et al.. (2016). Novelty-seeking trait predicts the effect of methylphenidate on creativity. Journal of Psychopharmacology. 31(5). 599–605. 25 indexed citations

18.

Nitzan, Uri, Kfir Feffer, Yuval Bloch, et al.. (2013). Consenting Not to Be Informed. The Journal of Nervous and Mental Disease. 201(4). 345–347. 3 indexed citations

19.

Feffer, Kfir, Uri Nitzan, Pesach Lichtenberg, Shaul Lev‐Ran, & Silvana Fennig. (2011). FC31-02 - Is it ethical not to prescribe placebo? the patient's perspective on the usage of placebo for the treatment of depression - a comparative study. European Psychiatry. 26(S2). 1990–1990. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact